SBI Securities’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68K Buy
51,479
+6,603
+15% +$9.05K ﹤0.01% 1060
2026
Q1
$61.5K Sell
44,876
-356
-0.8% -$539 ﹤0.01% 1016
2025
Q4
$59.3K Sell
45,232
-305
-0.7% -$421 ﹤0.01% 1020
2025
Q3
$57.8K Buy
45,537
+2,058
+5% +$2.66K ﹤0.01% 1030
2025
Q2
$57K Sell
43,479
-12,600
-22% -$17.6K ﹤0.01% 1015
2025
Q1
$81.9K Buy
56,079
+2,308
+4% +$4.08K ﹤0.01% 816
2024
Q4
$113K Buy
+53,771
New +$105K ﹤0.01% 719

Other funds holding MNOV

SBI Securities's MNOV Position: Q2 2026 in Review

SBI Securities increased its MediciNova (MNOV) stake by 15% in Q2 2026, buying an estimated $9.05K and bringing the position to 51,479 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

SBI Securities first reported a position in MNOV in Q4 2024 and has held it in 7 quarters since. The position peaked at $113K in Q4 2024. 28 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

  • SBI Securities held 51,479 shares of MediciNova worth $68K as of Q2 2026.
  • SBI Securities bought 6,603 MediciNova shares in Q2 2026, an estimated $9.05K.
  • MediciNova made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1060 holding.
  • SBI Securities first reported a position in MediciNova in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's MediciNova position peaked at $113K in Q4 2024.
  • 28 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.